Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1308 in Advanced Cervical Cancer
NCT06123884Phase 3Recruiting
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Dec 2023
- Primary completion
- Sep 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of BAT1308 in Cervical Cancer (CC), sponsored by Bio-Thera Solutions, Ltd.. Started Dec 2023; status: recruiting.
02
Drugs
BAT1308
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT06123884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123884.